Evidence map›Paper›PMID 41618385›Full record

ArticleJournal of cheminformatics2026

Chemical genomics language model toward reliable and explainable compound-protein interaction exploration.

Takuto Koyama, Hayato Tsumura, Ryunosuke Okita, Kimihiro Yamazaki, Aki Hasegawa, Keiko Imamura, Takashi Kato, Hiroaki Iwata, Ryosuke Kojima, Haruhisa Inoue and 2 more

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. HELM-BERT: Topology-Aware Representations for Chemically Modified Peptides.Journal of chemical information and modeling · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Takuto KoyamaGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Hayato TsumuraGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ryunosuke OkitaGraduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimo-Adachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Kimihiro YamazakiFujitsu Limited, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan.
Aki HasegawaGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Keiko ImamuraCenter for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takashi KatoFujitsu Limited, 4-1-1 Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan.
Hiroaki IwataFaculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.
Ryosuke KojimaGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Haruhisa InoueCenter for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan.
Shigeyuki MatsumotoGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. matsumoto.shigeyuki.4z@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0001-9329-6362
Yasushi OkunoGraduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. okuno.yasushi.4c@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0003-3596-4208

Funding

Grant-in-Aid for Transformative Research Areas (A) "Latent Chemical Space" JP24H01771Japan Agency for Medical Research and Development JP22bm0804034Japan Society for the Promotion of Science 22K06112Japan Society for the Promotion of Science JP24KJ1510
6 · The paper itself

Abstract

Accurate prediction of compound-protein interactions (CPIs) is crucial for chemical biology and drug discovery. Despite recent advancements, existing deep learning (DL)-based CPI models often struggle to simultaneously achieve high generalization performance, quantify prediction confidence, and ensure explainability. Here, we propose ChemGLaM, a chemical genomics language model designed to address these three crucial challenges, thereby enabling reliable and explainable CPI predictions. ChemGLaM integrates independently pre-trained chemical and protein language models through an interaction block with a cross-attention mechanism, achieving near state-of-the-art performance in predicting novel CPIs at a low computational cost. Incorporating uncertainty estimation and attention visualization enables ChemGLaM to enhance the success rate of virtual screening and to provide molecular insights into CPIs. To demonstrate the practical impact of ChemGLaM, we constructed a publicly available database containing large-scale CPI predictions for every possible pairing between all 20,434 human proteins and all 11,455 drugs and validated its practical applicability in a case study on amyotrophic lateral sclerosis. ChemGLaM marks an important step forward in addressing the challenges of AI-driven CPI exploration and drug discovery.Scientific ContributionThis study established a unified CPI prediction framework that simultaneously achieves high generalization performance, confidence quantification, and explainability. We leveraged this framework to create a community resource by constructing a comprehensive CPI database and demonstrated its practical utility by successfully prioritizing hit compounds and deconvoluting their targets in a phenotypic screening for amyotrophic lateral sclerosis.

Indexed as

Compound–protein interaction predictionDeep learningDrug discoveryLanguage model

Identifiers

PMID41618385
PMCPMC12922394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.